No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
Non-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurrence and progression may enable personalized follow-up sched...
Gespeichert in:
Veröffentlicht in: | PloS one 2020-03, Vol.15 (3), p.e0229384-e0229384 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0229384 |
---|---|
container_issue | 3 |
container_start_page | e0229384 |
container_title | PloS one |
container_volume | 15 |
creator | Evers, Jelle Grotenhuis, Anne J Aben, Katja K H Kiemeney, Lambertus A L M Vrieling, Alina |
description | Non-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurrence and progression may enable personalized follow-up schedules. Obesity and diabetes mellitus may be associated with a worse prognosis, but the evidence is limited and inconsistent. Our objective was to determine the associations of BMI and diabetes mellitus with risks of recurrence and progression among non-muscle invasive bladder cancer patients.
A population-based cohort of patients diagnosed with non-muscle invasive bladder cancer between 1995 and 2010 was retrospectively identified from the Netherlands Cancer Registry and invited to participate in the Nijmegen Bladder Cancer Study (n = 1,433). Average weight during adult life, height, and diabetes mellitus diagnosis were self-reported by use of a questionnaire. Clinical follow-up data were retrieved from medical files. Associations were quantified using proportional hazard analyses. For all analyses, minimal adjustment sets were selected using a Directed Acyclic Graph.
Fourteen percent of the patients indicated to be diagnosed with diabetes mellitus, and more than half was overweight (45%) or obese (9%). Compared to healthy weight, overweight and obesity were not associated with risk of recurrence (adjusted hazard ratio (HR) = 1.02; 95% confidence interval (CI): 0.86-1.22, and HR = 1.02; 95% CI: 0.76-1.38, respectively) and overall progression (HR = 1.04; 95% CI: 0.74-1.44, and HR = 1.20; 95% CI: 0.69-2.09, respectively). Also, no clear associations of diabetes mellitus with risk of recurrence (HR = 1.22; 95% CI: 0.98-1.54) and overall progression (HR = 1.16; 95% CI: 0.76-1.76) were found.
Average BMI during adult life and diabetes mellitus were not clearly associated with risk of recurrence or progression in non-muscle invasive bladder cancer. Prospective cohort studies with detailed information on BMI and diabetes mellitus before and after diagnosis are needed to confirm these findings. |
doi_str_mv | 10.1371/journal.pone.0229384 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2382995857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A618524020</galeid><doaj_id>oai_doaj_org_article_106206717fa84e2dacb2215e56147f11</doaj_id><sourcerecordid>A618524020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-d2f475a51adaa76309e3f0563a8f402d8ad6950ddf867da861cd86ba5998b4673</originalsourceid><addsrcrecordid>eNqNk12L1DAUhoso7rr6D0QDgujFjPlo0vRGWBc_BlYX_LoNp0k6k6FtxqQdFf-8mZnuMpW9kFwkJM95T86bnCx7TPCcsIK8WvshdNDMN76zc0xpyWR-JzslJaMzQTG7e7Q-yR7EuMaYMynE_eyEUUpwXpDT7M8nj3RjISCI0WsHvfNdRL5GYIamR28-LhB0BhkHle1tRK1tGtcPEf10_Qp1vpu1Q0wKyHVbiG5rUdWAMTYgDZ1OU7B6CMGm9V5oE_wy2BhTmofZvRqaaB-N81n27d3brxcfZpdX7xcX55czLUrazwyt84IDJ2AACsFwaVmNuWAg6xxTI8GIkmNjaikKA1IQbaSogJelrHJRsLPs6UF30_ioRt-iokzSsuSS74jFgTAe1moTXAvht_Lg1H7Dh6WC0LtUpiI4GSoKUtQgc0sN6CqZyS0XJC9qQpLW6zHbULXWaNv1AZqJ6PSkcyu19FtV4DKX--u-GAWC_zHY2KvWRZ1sh876YX9vxgkX5Q599g96e3UjtYRUgOtqn_Lqnag6F0RymlzEiZrfQqVhbOt0-mS1S_uTgJeTgMT09le_hCFGtfjy-f_Zq-9T9vkRu7LQ9Kvom2H_M6dgfgB18DEGW9-YTLDa9ci1G2rXI2rskRT25PiBboKum4L9BWXtDHg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2382995857</pqid></control><display><type>article</type><title>No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Evers, Jelle ; Grotenhuis, Anne J ; Aben, Katja K H ; Kiemeney, Lambertus A L M ; Vrieling, Alina</creator><contributor>Amankwah, Ernest K.</contributor><creatorcontrib>Evers, Jelle ; Grotenhuis, Anne J ; Aben, Katja K H ; Kiemeney, Lambertus A L M ; Vrieling, Alina ; Amankwah, Ernest K.</creatorcontrib><description>Non-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurrence and progression may enable personalized follow-up schedules. Obesity and diabetes mellitus may be associated with a worse prognosis, but the evidence is limited and inconsistent. Our objective was to determine the associations of BMI and diabetes mellitus with risks of recurrence and progression among non-muscle invasive bladder cancer patients.
A population-based cohort of patients diagnosed with non-muscle invasive bladder cancer between 1995 and 2010 was retrospectively identified from the Netherlands Cancer Registry and invited to participate in the Nijmegen Bladder Cancer Study (n = 1,433). Average weight during adult life, height, and diabetes mellitus diagnosis were self-reported by use of a questionnaire. Clinical follow-up data were retrieved from medical files. Associations were quantified using proportional hazard analyses. For all analyses, minimal adjustment sets were selected using a Directed Acyclic Graph.
Fourteen percent of the patients indicated to be diagnosed with diabetes mellitus, and more than half was overweight (45%) or obese (9%). Compared to healthy weight, overweight and obesity were not associated with risk of recurrence (adjusted hazard ratio (HR) = 1.02; 95% confidence interval (CI): 0.86-1.22, and HR = 1.02; 95% CI: 0.76-1.38, respectively) and overall progression (HR = 1.04; 95% CI: 0.74-1.44, and HR = 1.20; 95% CI: 0.69-2.09, respectively). Also, no clear associations of diabetes mellitus with risk of recurrence (HR = 1.22; 95% CI: 0.98-1.54) and overall progression (HR = 1.16; 95% CI: 0.76-1.76) were found.
Average BMI during adult life and diabetes mellitus were not clearly associated with risk of recurrence or progression in non-muscle invasive bladder cancer. Prospective cohort studies with detailed information on BMI and diabetes mellitus before and after diagnosis are needed to confirm these findings.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0229384</identifier><identifier>PMID: 32210471</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Age ; Analysis ; Biology and Life Sciences ; Bladder ; Bladder cancer ; Body height ; Body mass index ; Body weight ; Cancer ; Cancer patients ; Cancer recurrence ; Cancer research ; Confidence intervals ; Development and progression ; Diabetes ; Diabetes mellitus ; Diagnosis ; Family medical history ; Health aspects ; Health hazards ; Health risks ; Health sciences ; Insulin resistance ; Invasiveness ; Lifestyles ; Medical diagnosis ; Medical prognosis ; Medicine and Health Sciences ; Muscles ; Obesity ; Overweight ; Patients ; Professional associations ; Prognosis ; Recurrence (Disease) ; Risk ; Schedules ; Smoking ; Studies ; Tumor necrosis factor-TNF ; Tumors ; Type 2 diabetes ; Urology ; Weight</subject><ispartof>PloS one, 2020-03, Vol.15 (3), p.e0229384-e0229384</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Evers et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Evers et al 2020 Evers et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-d2f475a51adaa76309e3f0563a8f402d8ad6950ddf867da861cd86ba5998b4673</citedby><cites>FETCH-LOGICAL-c692t-d2f475a51adaa76309e3f0563a8f402d8ad6950ddf867da861cd86ba5998b4673</cites><orcidid>0000-0002-8178-2125</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094867/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094867/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32210471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Amankwah, Ernest K.</contributor><creatorcontrib>Evers, Jelle</creatorcontrib><creatorcontrib>Grotenhuis, Anne J</creatorcontrib><creatorcontrib>Aben, Katja K H</creatorcontrib><creatorcontrib>Kiemeney, Lambertus A L M</creatorcontrib><creatorcontrib>Vrieling, Alina</creatorcontrib><title>No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Non-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurrence and progression may enable personalized follow-up schedules. Obesity and diabetes mellitus may be associated with a worse prognosis, but the evidence is limited and inconsistent. Our objective was to determine the associations of BMI and diabetes mellitus with risks of recurrence and progression among non-muscle invasive bladder cancer patients.
A population-based cohort of patients diagnosed with non-muscle invasive bladder cancer between 1995 and 2010 was retrospectively identified from the Netherlands Cancer Registry and invited to participate in the Nijmegen Bladder Cancer Study (n = 1,433). Average weight during adult life, height, and diabetes mellitus diagnosis were self-reported by use of a questionnaire. Clinical follow-up data were retrieved from medical files. Associations were quantified using proportional hazard analyses. For all analyses, minimal adjustment sets were selected using a Directed Acyclic Graph.
Fourteen percent of the patients indicated to be diagnosed with diabetes mellitus, and more than half was overweight (45%) or obese (9%). Compared to healthy weight, overweight and obesity were not associated with risk of recurrence (adjusted hazard ratio (HR) = 1.02; 95% confidence interval (CI): 0.86-1.22, and HR = 1.02; 95% CI: 0.76-1.38, respectively) and overall progression (HR = 1.04; 95% CI: 0.74-1.44, and HR = 1.20; 95% CI: 0.69-2.09, respectively). Also, no clear associations of diabetes mellitus with risk of recurrence (HR = 1.22; 95% CI: 0.98-1.54) and overall progression (HR = 1.16; 95% CI: 0.76-1.76) were found.
Average BMI during adult life and diabetes mellitus were not clearly associated with risk of recurrence or progression in non-muscle invasive bladder cancer. Prospective cohort studies with detailed information on BMI and diabetes mellitus before and after diagnosis are needed to confirm these findings.</description><subject>Age</subject><subject>Analysis</subject><subject>Biology and Life Sciences</subject><subject>Bladder</subject><subject>Bladder cancer</subject><subject>Body height</subject><subject>Body mass index</subject><subject>Body weight</subject><subject>Cancer</subject><subject>Cancer patients</subject><subject>Cancer recurrence</subject><subject>Cancer research</subject><subject>Confidence intervals</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>Family medical history</subject><subject>Health aspects</subject><subject>Health hazards</subject><subject>Health risks</subject><subject>Health sciences</subject><subject>Insulin resistance</subject><subject>Invasiveness</subject><subject>Lifestyles</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Muscles</subject><subject>Obesity</subject><subject>Overweight</subject><subject>Patients</subject><subject>Professional associations</subject><subject>Prognosis</subject><subject>Recurrence (Disease)</subject><subject>Risk</subject><subject>Schedules</subject><subject>Smoking</subject><subject>Studies</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumors</subject><subject>Type 2 diabetes</subject><subject>Urology</subject><subject>Weight</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk12L1DAUhoso7rr6D0QDgujFjPlo0vRGWBc_BlYX_LoNp0k6k6FtxqQdFf-8mZnuMpW9kFwkJM95T86bnCx7TPCcsIK8WvshdNDMN76zc0xpyWR-JzslJaMzQTG7e7Q-yR7EuMaYMynE_eyEUUpwXpDT7M8nj3RjISCI0WsHvfNdRL5GYIamR28-LhB0BhkHle1tRK1tGtcPEf10_Qp1vpu1Q0wKyHVbiG5rUdWAMTYgDZ1OU7B6CMGm9V5oE_wy2BhTmofZvRqaaB-N81n27d3brxcfZpdX7xcX55czLUrazwyt84IDJ2AACsFwaVmNuWAg6xxTI8GIkmNjaikKA1IQbaSogJelrHJRsLPs6UF30_ioRt-iokzSsuSS74jFgTAe1moTXAvht_Lg1H7Dh6WC0LtUpiI4GSoKUtQgc0sN6CqZyS0XJC9qQpLW6zHbULXWaNv1AZqJ6PSkcyu19FtV4DKX--u-GAWC_zHY2KvWRZ1sh876YX9vxgkX5Q599g96e3UjtYRUgOtqn_Lqnag6F0RymlzEiZrfQqVhbOt0-mS1S_uTgJeTgMT09le_hCFGtfjy-f_Zq-9T9vkRu7LQ9Kvom2H_M6dgfgB18DEGW9-YTLDa9ci1G2rXI2rskRT25PiBboKum4L9BWXtDHg</recordid><startdate>20200325</startdate><enddate>20200325</enddate><creator>Evers, Jelle</creator><creator>Grotenhuis, Anne J</creator><creator>Aben, Katja K H</creator><creator>Kiemeney, Lambertus A L M</creator><creator>Vrieling, Alina</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8178-2125</orcidid></search><sort><creationdate>20200325</creationdate><title>No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression</title><author>Evers, Jelle ; Grotenhuis, Anne J ; Aben, Katja K H ; Kiemeney, Lambertus A L M ; Vrieling, Alina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-d2f475a51adaa76309e3f0563a8f402d8ad6950ddf867da861cd86ba5998b4673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Analysis</topic><topic>Biology and Life Sciences</topic><topic>Bladder</topic><topic>Bladder cancer</topic><topic>Body height</topic><topic>Body mass index</topic><topic>Body weight</topic><topic>Cancer</topic><topic>Cancer patients</topic><topic>Cancer recurrence</topic><topic>Cancer research</topic><topic>Confidence intervals</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>Family medical history</topic><topic>Health aspects</topic><topic>Health hazards</topic><topic>Health risks</topic><topic>Health sciences</topic><topic>Insulin resistance</topic><topic>Invasiveness</topic><topic>Lifestyles</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Muscles</topic><topic>Obesity</topic><topic>Overweight</topic><topic>Patients</topic><topic>Professional associations</topic><topic>Prognosis</topic><topic>Recurrence (Disease)</topic><topic>Risk</topic><topic>Schedules</topic><topic>Smoking</topic><topic>Studies</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumors</topic><topic>Type 2 diabetes</topic><topic>Urology</topic><topic>Weight</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evers, Jelle</creatorcontrib><creatorcontrib>Grotenhuis, Anne J</creatorcontrib><creatorcontrib>Aben, Katja K H</creatorcontrib><creatorcontrib>Kiemeney, Lambertus A L M</creatorcontrib><creatorcontrib>Vrieling, Alina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evers, Jelle</au><au>Grotenhuis, Anne J</au><au>Aben, Katja K H</au><au>Kiemeney, Lambertus A L M</au><au>Vrieling, Alina</au><au>Amankwah, Ernest K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020-03-25</date><risdate>2020</risdate><volume>15</volume><issue>3</issue><spage>e0229384</spage><epage>e0229384</epage><pages>e0229384-e0229384</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Non-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurrence and progression may enable personalized follow-up schedules. Obesity and diabetes mellitus may be associated with a worse prognosis, but the evidence is limited and inconsistent. Our objective was to determine the associations of BMI and diabetes mellitus with risks of recurrence and progression among non-muscle invasive bladder cancer patients.
A population-based cohort of patients diagnosed with non-muscle invasive bladder cancer between 1995 and 2010 was retrospectively identified from the Netherlands Cancer Registry and invited to participate in the Nijmegen Bladder Cancer Study (n = 1,433). Average weight during adult life, height, and diabetes mellitus diagnosis were self-reported by use of a questionnaire. Clinical follow-up data were retrieved from medical files. Associations were quantified using proportional hazard analyses. For all analyses, minimal adjustment sets were selected using a Directed Acyclic Graph.
Fourteen percent of the patients indicated to be diagnosed with diabetes mellitus, and more than half was overweight (45%) or obese (9%). Compared to healthy weight, overweight and obesity were not associated with risk of recurrence (adjusted hazard ratio (HR) = 1.02; 95% confidence interval (CI): 0.86-1.22, and HR = 1.02; 95% CI: 0.76-1.38, respectively) and overall progression (HR = 1.04; 95% CI: 0.74-1.44, and HR = 1.20; 95% CI: 0.69-2.09, respectively). Also, no clear associations of diabetes mellitus with risk of recurrence (HR = 1.22; 95% CI: 0.98-1.54) and overall progression (HR = 1.16; 95% CI: 0.76-1.76) were found.
Average BMI during adult life and diabetes mellitus were not clearly associated with risk of recurrence or progression in non-muscle invasive bladder cancer. Prospective cohort studies with detailed information on BMI and diabetes mellitus before and after diagnosis are needed to confirm these findings.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>32210471</pmid><doi>10.1371/journal.pone.0229384</doi><tpages>e0229384</tpages><orcidid>https://orcid.org/0000-0002-8178-2125</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2020-03, Vol.15 (3), p.e0229384-e0229384 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2382995857 |
source | DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Age Analysis Biology and Life Sciences Bladder Bladder cancer Body height Body mass index Body weight Cancer Cancer patients Cancer recurrence Cancer research Confidence intervals Development and progression Diabetes Diabetes mellitus Diagnosis Family medical history Health aspects Health hazards Health risks Health sciences Insulin resistance Invasiveness Lifestyles Medical diagnosis Medical prognosis Medicine and Health Sciences Muscles Obesity Overweight Patients Professional associations Prognosis Recurrence (Disease) Risk Schedules Smoking Studies Tumor necrosis factor-TNF Tumors Type 2 diabetes Urology Weight |
title | No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T05%3A56%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20clear%20associations%20of%20adult%20BMI%20and%20diabetes%20mellitus%20with%20non-muscle%20invasive%20bladder%20cancer%20recurrence%20and%20progression&rft.jtitle=PloS%20one&rft.au=Evers,%20Jelle&rft.date=2020-03-25&rft.volume=15&rft.issue=3&rft.spage=e0229384&rft.epage=e0229384&rft.pages=e0229384-e0229384&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0229384&rft_dat=%3Cgale_plos_%3EA618524020%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2382995857&rft_id=info:pmid/32210471&rft_galeid=A618524020&rft_doaj_id=oai_doaj_org_article_106206717fa84e2dacb2215e56147f11&rfr_iscdi=true |